Yes there are a lot of SOI but I think long term that the SP can go up if they can monetise their product. It sounds like multiple applications (cancer/antiviral/atherosclerosis). If they can get one application over the line and bring in income, then hopefully won't need too many more capital raises to further dilute. This is a long hold.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.010(9.09%) |
Mkt cap ! $8.487M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $10.00K | 100.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88302 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 81918 | 2 |
View Market Depth
| Last trade - 11.04am 27/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |